Radiomics in esophageal and gastric cancer

Bert-Ram Sah, Kasia Owczarczyk, Musib Siddique, Gary J.R. Cook, Vicky Goh*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)


Esophageal, esophago-gastric, and gastric cancers are major causes of cancer morbidity and cancer death. For patients with potentially resectable disease, multi-modality treatment is recommended as it provides the best chance of survival. However, quality of life may be adversely affected by therapy, and with a wide variation in outcome despite multi-modality therapy, there is a clear need to improve patient stratification. Radiomic approaches provide an opportunity to improve tumor phenotyping. In this review we assess the evidence to date and discuss how these approaches could improve outcome in esophageal, esophago-gastric, and gastric cancer.

Original languageEnglish
JournalAbdominal Radiology
Early online date16 Aug 2018
Publication statusE-pub ahead of print - 16 Aug 2018


  • Computed tomography
  • Esophageal cancer
  • Esophagogastric junction cancer
  • Magnetic resonance imaging
  • Positron emission tomography
  • Radiomics


Dive into the research topics of 'Radiomics in esophageal and gastric cancer'. Together they form a unique fingerprint.

Cite this